Orthopedic Center News & Announcements

In The News this week, we celebrate CHOP being named a top children’s hospitals in the nation for the 17th consecutive year.

News this week highlights recipients of the Foerderer Grants and CHOP’s designation as a Tier 1 Center of Excellence for telomere biology disorders.

Results from a large retrospective study of patients surgically treated for Patellar Sleeve Fractures revealed in most pediatric patients with displaced fractures, surgery was effective in restoring full range of motion and enabled them to return to their regular activities.

The hourly rates for flow cytometry and cell sorting services in the Flow Cytometry Core have been decreased.

This week’s In The News highlights studies on influenza, antibiotic use, and e-scooter accidents.

CHOP researchers found children who take only ibuprofen or acetaminophen after routine elbow surgery report similar pain control to patients who take opioids.

In research presented at the AAP annual meeting, CHOP experts found the number of injuries associated with riding e-scooters rose most among teenage boys.

The American Society for Bone and Mineral Research honored Dr. Fanxin Long for his signification contributions to the field.

The new Center for Outcomes Research in Surgery provides a patient-centered approach to improving outcomes in children with surgical conditions.

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

Research from the Minds Matter Concussion Program at CHOP influenced new, international guidelines for the diagnosis, management, and prevention of concussion in sport.

Learn about novel findings from our Children’s Hospital of Philadelphia researchers.

Identified by CHOP researchers, palovarotene is the first drug approved (in Canada) for fibrodysplasia ossificans progressiva, a severe bone disease.

Palovarotene is the first approved drug against fibrodysplasia ossificans progressiva (FOP), a rare and often fatal disease.

This week’s In the News features new study on measuring vision changes in patients with neurofibromatosis type 1, and other research highlights.

CHOP researchers identified the drug, palovarotene, to treat fibrodysplasia ossificans progressive (FOP).

CHOP and its individual departments ranked high in U.S. News and World Report’s Best Children’s Hospitals for 2021-2022.

The February Featured Research Trainee, Kaylia Duncan, reflects on Black History Month and her scientific career.

Study shows deep decline in number of pediatric patients visiting the emergency department for asthma treatment during first month of COVID-19 pandemic. This and more In the News.

U.S. News &World Report once again ranked CHOP as one of the top children’s hospitals in the United States

CHOP stays on top of COVID-19 research, from multisystem inflammatory syndrome in children to social distancing’s impact on fractures.

Children ages 5 to 11 years diagnosed with a concussion had similar rates of vision and balance deficits to adolescents with concussions.

Universally screening pediatric patients for COVID-19 before they undergo surgical procedures enables hospitals to improve safety.

Study finds COVID-19 social distancing has led to decrease in pediatric fractures, but increase in proportion of fractures sustained at home.

New study details the ability to successfully deliver high-quality pediatric orthopedic care via video visits during the COVID-19 pandemic.

PolicyLab model updates reveal weather is having a greater impact on the spread of COVID-19 than previously indicated. This and more In the News.

Study by CHOP researchers finds debilitating lawnmower injuries continue to occur throughout U.S., despite improvements in lawnmower design.

U.S.News & World Report has ranked CHOP among the nation’s Best Children’s Hospitals — again!

This week's roundup of research headlines at CHOP is all about making connections.

From antibiotic stewardship in the NICU to reducing child mortality rates, here's your bi-weekly update on CHOP research news.

Our weekly installment of In the News keeps an eye out for the latest research happenings. This week we're excited to report on a second award for an innovative technology solution to access, filter, and harness emerging disease updates.

This week’s stories have elements that sound like fiction, but all are real, new scientific and medical findings: A condition that turns the body’s soft tissues into bone has new hope for a future treatment. Genetic superheroes walk among us, and they may not even know it. And…

Eiki Koyama, DDS, PhD and Hyun-Duck Nah, DMD, PhD, from the Children's Hospital of Philadelphia, recently received a grant from the National Institute of Dental & Craniofacial Research to study the development of the TMJ.